Why Novavax Stock Is Jumping Again Today
Shares of Novavax (NASDAQ: NVAX) were jumping 8.2% as of 11:58 a.m. EDT on Wednesday. This gain appears to be related to news that the company will soon initiate a phase 1/2 clinical study evaluating three COVID-19 vaccine constructs that use the Matrix-M1 adjuvant in targeting the coronavirus beta and delta variants.
Novavax didn't issue a press release announcing the planned clinical study targeting coronavirus variants. Instead, details about the study were posted on the National Institute of Health's ClinicalTrials.gov website.
Image source: Getty Images.
Source Fool.com
